In PAH, Pim-1 has been identified as a potential biomarker, with plasma Pim-1 levels correlating directly to disease severity [91], and increased expression of Pim-1 was observed in PAH patients’ pulmonary artery smooth muscle cells (PASMCs), compared to healthy controls [93]. This evidence concerns the gene PIM1 and pulmonary arterial hypertension.